1.
Study on the Synthetic Process of Erlotinib and Its Intermediates
厄洛替尼及其中间体的合成工艺研究
2.
Clinical Experience of Treating Senile Advanced Non-small Cell Lung Cancer by Erlotinib
厄洛替尼治疗老年晚期NSCLC的临床观察
3.
Erlotinib in the trentment of Advanced Non-small-cell Lung Cancer:A Systematic Review
厄洛替尼治疗晚期非小细胞肺癌的系统评价
4.
The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer
厄洛替尼治疗非小细胞肺癌脑转移初步分析
5.
Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer:A Report of 92 Eases
厄洛替尼治疗晚期非小细胞肺癌92例临床观察
6.
Clinical Observation of Erlotinib as the First-line Treatment for Patients with Advanced Non-small Cell Lung Cancer
厄洛替尼一线治疗晚期非小细胞肺癌临床观察
7.
Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer
厄洛替尼治疗晚期非小细胞肺癌的临床研究
8.
Erlotinib as the Second-line Treatment for NSCLC Patients of Stage Ⅲb/Ⅳ
厄洛替尼二线治疗非小细胞肺癌临床疗效观察
9.
Research of Erlotinib for Patients with Advanced NSCLC
厄洛替尼治疗晚期非小细胞肺癌的临床疗效观察
10.
Efficacy of erlotinib plus best supportive care in treatment of advanced non-small cell lung cancer
厄洛替尼联合最佳支持疗法治疗晚期非小细胞肺癌的临床观察
11.
Pooled Analysis of the Trials of Erlotinib Monotherapy for Epidermal Growth Factor Receptor (EGFR)-mutant Advanced Non-small Cell Lung Cancer
厄洛替尼单药治疗EGFR突变的晚期NSCLC患者试验汇合分析
12.
The Impact of Smoking Status on the Efficacy of Erlotinib in Patients with Advanced Non-small Cell Lung Cancer
吸烟状况对厄洛替尼治疗晚期非小细胞肺癌疗效影响
13.
Clinical Observation of Erlotinib in the Treatment of Advanced and Previously Treated Non-small Cell Lung Cancer
厄洛替尼治疗晚期复治非小细胞肺癌45例的临床观察
14.
A Retrospective Analysis of Erlotinib and TP/GP Regimen in the Treatment of Advanced Non-small Cell Lung Cancer
厄洛替尼与TP/GP方案治疗晚期非小细胞肺癌的回顾性分析
15.
A Clinical Observation of Concomitant Therapy of Erlotinib and Whole Brain Radiotherapy in Patients of NSCLC Combined with Brain Metastases
厄洛替尼联合全脑放疗治疗非小细胞肺癌脑转移的临床观察
16.
Observation of Erlotinib in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer and COPD
厄洛替尼治疗晚期非小细胞肺癌合并COPD病人的临床观察
17.
The correlation between skin rash and the effi cacy of erlotinib in patients with advanced non-small cell lung cancer
皮疹与厄洛替尼治疗晚期非小细胞肺癌疗效相关性研究
18.
Effect of teaching-in-classroom health education on patients with erlotinib-related rashes
授课式健康教育在厄洛替尼致皮疹患者中的应用